BARCLAYS PLC - PROTALIX BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$77
+196.2%
46,511
+251.6%
0.00%
Q2 2023$26
+550.0%
13,230
+561.5%
0.00%
Q1 2023$4
+33.3%
2,0000.0%0.00%
Q4 2022$3
-99.8%
2,0000.0%0.00%
Q3 2022$2,0000.0%2,0000.0%0.00%
Q2 2022$2,0000.0%2,0000.0%0.00%
Q1 2022$2,0002,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$2,513,0000.04%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$27,0000.02%
MEITAV INVESTMENT HOUSE LTD 244,332$256,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$139,0000.00%
IHT Wealth Management, LLC 22,000$23,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BANK OF AMERICA CORP /DE/ 3,027$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DAVENPORT & Co LLC 22,000$23,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders